Malignant Melanoma
Malignant melanoma is a type of skin cancer that develops from melanocytes, the pigment-producing cells in the skin. It can appear as a new or changing mole and may spread to other parts of the body if not treated early.
Metastatic Melanoma: Early Detection of Side Effects
We are investigating whether a special imaging technique can help identify early side effects in patients receiving immune therapy for metastatic melanoma. This study aims to improve monitoring of immune-related side effects.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have metastasized or irresectable melanoma (advanced skin cancer)?
- Are you currently pregnant or breastfeeding?
- Have you had major surgery in the past 4 weeks?
- Have you received any chemotherapy or radiotherapy in the past 2 weeks?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Zirconium
Crefmirlimab Berdoxam
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Tuebingen AöR
Radiology Dept. of Nuclear Medicine & Molecular Imaging
Tübingen, Germany
Sponsor: Universitaetsklinikum Tuebingen AöR
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.